Publicaciones

​Publicaciones del PII DE INFECCIONES RESPIRATORIAS

  •  Huerta A, Soler N, Esperatti M, Menéndez R, Gimeno A, Zalacaín R, Mir N, Aguado JM, Torres A. Importance of aspergillus spp. Isolation in Acute Exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respir Res. 2014 Feb; 11;15:17 .
  • Bello S, Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Alfageme I, Rodriguez de Castro F, Rello J, Molinos L, Ruiz-Manzano J. Tobacco smoking increase the risk of death from pneumococcal pneumonia. Chest 2014[Epub ahead of print].
  • Ferrer M, Torres A, Martinez R, Ramirez P, Polverino E, Montull B, Sialer S, Niederman MS, Agusti A, Menendez R. Inhaled corticosteroids and systemic inflammatory response in community/acquired pneumonia. A clinical prospective study. Respirology 2014 Aug;19(6):929-35. 
  • Martín-Loeches I, Vallés X, Menéndez R, Sibila O, Montull B, Cilloniz C, Artigas A, Torres A. Predicting treatment failure in patients with community-acquired pneumonia a case-control study. Respir Res. 2014 Jul;15(1):75.
  • Bello S, Mincholé E, Fandós S, Lasierra AB, Simón AL, Panadero C, Lapresta C, Menéndez R, Torres A. Inflammatory response in mixed viral-bacterial community-acquired pneumonia. BMC Pulm Med 214 Jul;14:123.
  • Crisafulli E, Guerrero M, Menéndez R, Huerta A, Martínez R, Gimeno A,  Soler N, Torres A. Inhaled corticosteroids so not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation. Respir Care 2014 Jul[Epub ahead of print].
  • Terraneo A, Polverino E, Cilloniz C, Amaro R, Vennera MD, Gabarrus A, Montull B, Moreno E, Menéndez R, Centanni S, Torres A. Severity outcomes of community-acquired pneumonia in asthmatic patients. Respir Med 2014 Sep;[Epub ahead of print].
  • Crisafulli E, Torres A, Huerta A, Méndez R, Guerrero M, Martínez R,  Liapikou A, Soler N, Sethi S, Menéndez R. C-reactive protein at discharge. Diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chonic obstructive disease. COPD. 2014 Oct[Epub ahead of print]
  • Polverino E, Cilloniz C, Dambrava P, Gabarrús A, Ferrer M, Agustí C, Prina E, Montull B, Menéndez R, Niederman MS, Torres A. Systemic corticosteroids for Community-Acquired Pneumonia: reasons for use and lack benefit on outcome. Respirology 2013 Feb;18(2):263-71.
  • Prina E, Ferrer M, Ranzani OT, Polverino E, Cilloniz C, Moreno E, Mensa J, Montull B, Menéndez R, Cosentini R, Torres A. Thombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest 2013 Mar;143(3):767-75.
  • Crisafulli E, Menéndez R, Huerta A, Martínez R, Montull B, Clini E, Torres A. Systemic inflammatoty pattern of community-acquired pneumonia (CAP) patients with and without chonic obstructive disease (COPD). Chest 2013 Apr:143(4):1009-17.
  • Sellares J, López-Giraldo A, Lucena C, Cilloniz C, Amaro R, Polverino E, Ferrer, Menéndez R. Influence of previous use of inhaled corticosids on the development of pleural effusion in community-acquired pneumonia. Am J Respir Crit Care Med. 2013, Jun;187(11):1241-8.
  • Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrús A, Menéndez R, Mensa J, Blasi F, Torres A.  Impact of age and comorbidity on etiology and outcome in community-acquired pneumonia. Chest 2013 Sep;144(3):999-1007.
  • Huerta A, Crisafulli E, Menéndez R, Martínez R, Soler N, Guerrero M, Montull B, Torres A. Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics. Chest 2013 Jul;[Epub ahead of print].
  • Polverino E, Torres A, Menéndez R, Cilloniz C, Valles JM, Capelastegui A, Marcos MA, Alfageme I, Zalacaín R, Almirall J, Molinos L, Bello S, Rodrguez F, Blanquer J, Dorado A, Llevat N, Rello J; HCAP Study Investigators.  Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax 2013 Nov;68(11):1007-14.
  • Torres A, Barberán J, Falguera M, Menéndez R, Molina J, Olaechea P, Rodriguez A; en nombre del grupo multidisciplinary para el manejo de la Neumonía Adquirida en la Comunidad. Multidisciplinary guidelines for the management of Community-Acquired Pneumonia. Med Clin (Barc) 2013 Mar;140(5):223e1-223e19
  • Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderias L, Martín-Villasclaras JJ, Bello S, Alfageme I, De Castro FR, Rello J, Molinos L, Ruiz- Manzano J. Initial Management of Pneumonia and Sepsis. Factors associated with improved outcomes. Eur Respir J. 2012 Jan;39(1):156-62. Editorial: G.W. Waterer and D. Lopez. Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause ans effect. Eur Respir J 2012 Jan;39:7-8.
  • Liapikou A, Polverino E, Ewig S, Cilloniz C, Marcos MA, Mensa J, Bello S, Martín-Loeches I, Menéndez R, Torres A.Severity and Outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J. 2012 Apr;39(4):855-61. 
  • Bello S, Lasierra AB, Mincholé E, Fandós S, Ruiz MA, Vera E, Ferrer M, Menéndez R, Torres A. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent on etiology. Eur Respir J. 2012 May;39(5):1144-55.
  • Menéndez R, Sahuquillo-Arce JM, Reyes S, Martínez R, Polverino E, Cillóniz C, Córdoba JG, Montull B, Torres A. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012 Jun;141(6):1537-45.
  • Menéndez R, Torres A, Reyes S, Zalacaín R, capelastegui A, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I; De Castro FR, Rello J, Molinos L, Ruiz-Manzano J. Compilance with guidelines-recommended processes in pneumonia: impact of health status and initial sings. PloS One. 2012;7(5):e37570.
  • Torres A, Ramírez P, Montull B, Menéndez R. Biomarkers and community-acquired pneumonia: tailoring management with biological data. Semin Respir Crit Care Med 2012 Jun;33(3):266-71.
  • Cilloniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, Gabarrús A, Marcos MA, Córdoba J, Mensa J, Torres A. Bacterial co-infection with H1N1 infection in patients dmitted with community-acquired pneumonia. J Infect 2012 Sep;65(3):223-30.
  • Cilloniz C, Ewig S, Polverino E, Muñoz-Almagro C, Marco F, Gabarrús A, Menéndez R, Mensa J, Torres A. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcome. Clin Microbiol Infect. 2012 Nov;18(11):1134-1142.
  • Polverino E, Cilloniz C, Bambrava, Gabarrús A, Ferrer M, agustí C, Prina E, Montull B, Menéndez R, Niederman MS, Torres A. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack benefit on outcome. Respirology 2012[Epub ahead of print].
  • Torres A, Barberán J, Bárcena M, Cañada JL, Cots JM, Falguera M, García-Rodriguez JA, Gómez F, Gonzalez del Castillo J, Gudiol F, Julián A, Menéndez R, Mensa J, Molina J, Nacerán K, Olaechea P, Quintano JA, Rodriguez A, Segura F. Guía multidisciplinar para el manejo de la Neumonía Adquirida en la Comunidad (GNAC). En prensa.
  • Riquelme R, Torres A, Rioseco ML, Ewig S, Cilloniz C, Riquelme M, Inzunza C, Polverino E, Gómez Y, Marcos MA, Contreras C, Gabarrús A, Fasce R. Community-Acquired Pneumonia during influenza season: a comparison between seasonal influenza vírus and novel influenza A(H1N1). Eur Respir J. 2011 Jul;38(1):106-11.
  • Reyes S, Montull  B, Martinez R, Córdoba J, Molina JM, Martí V, Martinez A, Menéndez R. Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality. Respir Méd 2011 Sep105(9):1404-11.
  • Martínez R, Menéndez R, Reyes S, Polverino E, Cilloniz C, Martinez A, Esquinas C, Filella X, Ramírez P, Torres A. Factors associated with inflmmatory cytokine patterns in Community-Acquired Pneumonia. Eur Respir J. 2011 Feb;37(2):393-9.
  • Ramírez P, Menéndez R, Torres A. Biomarkers and pneumonia: Should we all be using them?. Current Respiratory Medicine. 2011 Aug;7(4):262-7.
  • Ferrer M, Menéndez R, Amaro R, Torres A. The impact of guidelines on the outcomes of Community-Acquired and ventilator associated Pneumonia. Clin Chest Med 2011 Sep;32(3):491-505.
  • Ramírez P, Ferrer M, Martí V, Reyes S, Martinez R, Menéndez R, Ewig S, Torres A. A inflammatory response and prediction for Intensive Care Unit admision in severe Community-Acquired Pneumonia. Crit Care Med 2011 Oct;39(10):2211-7.
  • Menéndez R, Torres A, Aspa A, Capelastegui A, Prat C, Rodriguez de Castro F. Neumonía Adquirida em la Comunidad. Nueva normativa de la Sociedad Española de Neumologçia y Cirugía Torácica (SEPAR). Arch Bronconeumol 2010 Oct;46(10):453-8.
  • Polverino E, Dambrava P, Cilloniz C,  Balasso V, Marcos MA, Esquinas C, Mensa J, Ewig S, Torres A. Nursing home-acquired pneumonia: a 10 year single-center experience. Thorax 2010 Apr;65(4):354-9.
  • Espana PP, Capelastegui A,  Quintana JM, Bilbao A, Diez R, Pascual S, Zalacaín R, Menéndez R, Torres A. Validation and comparison of SCAP as a predictive score for identificatying low-risk patients in CAP. J. Infect 2010 Feb;60(2):106-13.
  • Falguera M, Trujanillo J, Caro S, Menéndez R, Carratalá J, Ruiz-Gonzalez A, Vilá M, García M, Porcel JM, Torres A. A prediction rule for estimating the risk of bacteraemia en patients with Community-Acquired Pneumonia. Clin Infect Dis 2009 Aug;49(3):409-16.
  • Yandiola PP, Capelastegui A, Quintana JM, Bilbao A, Díez R, Gorordo I, Zalacaín R, Menéndez R, Torres A. Pospective comparisonof severity scores for predicting clinically relevant outcomes for patients hospitalised with Community-Acquired Pneumonia. Chest 2009 Jun;135(6):1572-9
  • Capelastegui A, España PP, Quintana JM, Bilbao A, Menéndez R, Zalacaín R, Torres A. A development of a prognostic index for 90-day mortality among patients discharged alter hospitalization for Community-Acquired Pneumonia. Thorax 2009 Jun;64(6):496-501.